Skip to main content
Livermore
Livermore
ZHEN

Avid Bioservices, Inc.

CDMODelisted Feb 5, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0000704562

Avid Bioservices, Inc. was delisted on Feb 5, 2025; its insiders filed their last Form 4 on Feb 7, 2025; 196 institutions reported holding it in 13F filings for Q4 2024, worth $840.8M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Avid Bioservices, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Avid Bioservices, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Avid Bioservices, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Carleone JosephDirector0Feb 7, 20250
Sargen GregoryDirector0Feb 7, 20250
Hart Daniel RChief Financial Officer0Feb 7, 20250
Ziebell Mark RV. P., General Counsel0Feb 7, 20250
Mackey Catherine JDirector0Feb 7, 20250
Hancock Richard BDirector0Feb 7, 20250
Green Nicholas StewartPresident & CEO0Feb 7, 20250
Thoma JeanneDirector0Feb 7, 20250
Alegria Esther M.Director0Feb 7, 20250
Kwietniak Matthew R.Chief Commercial Officer0Feb 7, 20250
Richieri Richard A.Chief Operations Officer0IndirectFeb 7, 20250

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 11, 2022 (view filing)Jan 101 dayHart Daniel RChief Financial OfficerSSaleCommon Stock, $0.001 par value−877$21.58−$18.9K−3.0%28.0K after
Jan 11, 2022 (view filing)Jan 101 dayGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−3.21K$21.58−$69.4K−11.2%25.5K after
Jan 5, 2022 (view filing)Jan 32 daysZiebell Mark RV. P., General CounselSSaleCommon Stock, $0.001 par value−20.7K$27.65−$571.6K−73.6%7.43K after2 lots
Jan 5, 2022 (view filing)Jan 32 daysHart Daniel RChief Financial OfficerSSaleCommon Stock, $0.001 par value−500$29.07−$14.5K−1.8%27.3K after
Jan 5, 2022 (view filing)Jan 32 daysHancock Richard BDirectorSSaleCommon Stock, $0.001 par value−5.00K$27.53−$137.7K−12.4%35.2K after
Dec 29, 2021 (view filing)Dec 272 daysZiebell Mark RV. P., General CounselSSaleCommon Stock, $0.001 par value−6.83K$30.27−$206.7K−47.9%7.43K after
Dec 16, 2021 (view filing)Dec 151 dayZiebell Mark RV. P., General CounselSSaleCommon Stock, $0.001 par value−6.43K$24.57−$158.0K−31.1%14.3K after
Dec 3, 2021 (view filing)Dec 12 daysHancock Richard BDirectorSSaleCommon Stock, $0.001 par value−5.00K$30.90−$154.5K−13.2%32.8K after
Nov 17, 2021 (view filing)Nov 152 daysHancock Richard BDirectorSSaleCommon Stock, $0.001 par value−5.00K$32.46−$162.3K−13.2%32.8K after2 lots
Oct 12, 2021 (view filing)Oct 111 dayZiebell Mark RV. P., General CounselSSaleCommon Stock, $0.001 par value−349$22.37−$7.81K−2.4%14.3K after
Oct 12, 2021 (view filing)Oct 111 dayHart Daniel RChief Financial OfficerSSaleCommon Stock, $0.001 par value−760$22.37−$17.0K−2.8%26.9K after
Oct 12, 2021 (view filing)Oct 111 dayGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−2.79K$22.37−$62.3K−11.0%22.6K after
Aug 3, 2021 (view filing)Aug 21 dayGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−18.7K$25.56−$478.0K−48.5%19.9K after
Jul 13, 2021 (view filing)Jul 121 dayZiebell Mark RV. P., General CounselSSaleCommon Stock, $0.001 par value−7.21K$25.61−$184.6K−34.1%13.9K after2 lots
Jul 13, 2021 (view filing)Jul 121 dayHart Daniel RChief Financial OfficerSSaleCommon Stock, $0.001 par value−5.41K$25.61−$138.5K−17.2%26.1K after2 lots